stars 1 stars 2 stars 3

PUXANO operates as a platform-based biotech company, grounded in experimental structural biology and empowered by diffusion-based generative AI. We provide R&D services for pharmaceutical, biotechnology and agritech companies advancing protein therapeutics, vaccine development and crop protection. Thanks to our platform PROTAGON, propelled by proprietary molecular, structural and computational technologies, we can unlock targets previously deemed inaccessible or facilitate the streamlined design, production and validation of engineered proteins with exceptional efficiency. Current platforms are: - procondor, a software tool for automated protein construct design. - UltraP, a set of biotechnology workflows and tools for high-throughput protein production and biophysical characterization - PXN Grids, a portfolio of proprietary cryo-EM grids and sample preparation protocols resolving the major bottlenecks in cryoEM sample preparation. For more information, please visit our website 饾槃饾槃饾槃.饾椊饾槀饾槄饾棶饾椈饾椉.饾棸饾椉饾椇 or contact 饾椂饾椈饾棾饾椉@饾椊饾槀饾槄饾棶饾椈饾椉.饾棸饾椉饾椇.

PUXANO Questions

Wouter van Putte is the Founder and CEO PUXANO of PUXANO.

5 people are employed at PUXANO.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users